Literature DB >> 5957431

Congenital anomalies and viral infections in infants. The etiologic role of maternal viral infections.

H T Wright.   

Abstract

Some viruses, such as rubella and human cytomegalovirus, are known to cross the placental barrier and infect the fetus. In other cases of maternal viral infections, such as herpes simplex, evidence for transplacental passage is less convincing and fetal damage or neonatal disease may be coincidental or associated with perinatal infection. Certain cases of fetal or neonatal disease following maternal viral infections may be associated with disease in the mother which affects her metabolic processes or the placenta in such a way as to interfere with development of the fetus and infant. The possible effects of transplacental viral infections are several. Fetal loss may occur by means of abortion or stillbirth. There may be infection of the fetus, with clinical manifestations such as rash, or without clinical manifestations. The infant may be born with congenital defects, including such deformities as cataracts, cardiac anomalies, mental retardation or cerebral palsy. Although a number of maternal viral diseases have been etiologically incriminated in congenital defects, only two-rubella and cytomegalovirus infection-are definitely proved to be associated with anomalies or mental retardation in infants.

Entities:  

Mesh:

Year:  1966        PMID: 5957431      PMCID: PMC1516552     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  21 in total

1.  AN INFANT FATALITY ASSOCIATED WITH COXSACKIE B1 VIRUS.

Authors:  H T WRIGHT; K OKUYAMA; R M MCALLISTER
Journal:  J Pediatr       Date:  1963-09       Impact factor: 4.406

2.  Coxsackie virus infections of the newborn.

Authors:  J H GEAR
Journal:  Prog Med Virol       Date:  1958

3.  Abnormalities in offspring related to maternal rubella during pregnancy.

Authors:  A DEKABAN; J O'ROURKE; T CORNMAN
Journal:  Neurology       Date:  1958-05       Impact factor: 9.910

4.  Herpes zoster as a cause of congenital cataract.

Authors:  P A DUEHR
Journal:  Am J Ophthalmol       Date:  1955-02       Impact factor: 5.258

5.  The significance of poliomyelitis during pregnancy; an analysis of the literature and presentation of twenty-four new cases.

Authors:  V M BOWERS; D N DANFORTH
Journal:  Am J Obstet Gynecol       Date:  1953-01       Impact factor: 8.661

6.  A new laboratory aid in the clinical diagnosis of inclusion disease of infancy.

Authors:  G H FETTERMAN
Journal:  Am J Clin Pathol       Date:  1952-05       Impact factor: 2.493

7.  Viral hepatitis in the newborn; clinical features, epidemiology, and pathology.

Authors:  J STOKES; I J WOLMAN; M C BLANCHARD; J D FARQUHAR
Journal:  AMA Am J Dis Child       Date:  1951-08

8.  The role of viruses in the etiology of chromosomal abnormalities.

Authors:  W W Nichols
Journal:  Am J Hum Genet       Date:  1966-01       Impact factor: 11.025

9.  The epidemiology of chromosome aberrations.

Authors:  R W Day
Journal:  Am J Hum Genet       Date:  1966-01       Impact factor: 11.025

10.  Susceptibility of the Guinea Pig Fetus to the Submaxillary Gland Virus of Guinea Pigs.

Authors:  F S Markham; N P Hudson
Journal:  Am J Pathol       Date:  1936-03       Impact factor: 4.307

View more
  3 in total

1.  Cardiofacial syndrome. Congenital heart disease and facial weakness, a hitherto unrecognized association.

Authors:  G G Cayler
Journal:  Arch Dis Child       Date:  1969-02       Impact factor: 3.791

2.  Viral invasion of the amniotic cavity (VIAC) in the midtrimester of pregnancy.

Authors:  Maria-Teresa Gervasi; Roberto Romero; Gabriella Bracalente; Tinnakorn Chaiworapongsa; Offer Erez; Zhong Dong; Sonia S Hassan; Lami Yeo; Bo Hyun Yoon; Gil Mor; Luisa Barzon; Elisa Franchin; Valentina Militello; Giorgio Palù
Journal:  J Matern Fetal Neonatal Med       Date:  2012-05-30

Review 3.  HIV-exposed uninfected children: a growing population with a vulnerable immune system?

Authors:  L Afran; M Garcia Knight; E Nduati; B C Urban; R S Heyderman; S L Rowland-Jones
Journal:  Clin Exp Immunol       Date:  2014-04       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.